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Abstract
Background: Twelve of the 17 Sustainable Development Goals (SDGs) are related to malnutrition (both under- and
overnutrition), other behavioral, and metabolic risk factors. However, comparative evidence on the impact of behavioral
and metabolic risk factors on disease burden is limited in sub-Saharan Africa (SSA), including Ethiopia. Using data from
the Global Burden of Disease (GBD) Study, we assessed mortality and disability-adjusted life years (DALYs) attributable
to child and maternal undernutrition (CMU), dietary risks, metabolic risks and low physical activity for Ethiopia. The
results were compared with 14 other Eastern SSA countries.
Methods: Databases from GBD 2015, that consist of data from 1990 to 2015, were used. A comparative risk assessment
approach was utilized to estimate the burden of disease attributable to CMU, dietary risks, metabolic risks and low physical
activity. Exposure levels of the risk factors were estimated using spatiotemporal Gaussian process regression (ST-GPR) and
Bayesian meta-regression models.
Results: In 2015, there were 58,783 [95% uncertainty interval (UI): 43,653–76,020] or 8.9% [95% UI: 6.1–12.5] estimated all-
cause deaths attributable to CMU, 66,269 [95% UI: 39,367–106,512] or 9.7% [95% UI: 7.4–12.3] to dietary risks, 105,057 [95%
UI: 66,167–157,071] or 15.4% [95% UI: 12.8–17.6] to metabolic risks and 5808 [95% UI: 3449–9359] or 0.9% [95% UI: 0.6–1.1]
to low physical activity in Ethiopia. While the age-adjusted proportion of all-cause mortality attributable to CMU decreased
significantly between 1990 and 2015, it increased from 10.8% [95% UI: 8.8–13.3] to 14.5% [95% UI: 11.7–18.0] for dietary
risks and from 17.0% [95% UI: 15.4–18.7] to 24.2% [95% UI: 22.2–26.1] for metabolic risks. In 2015, Ethiopia ranked among
the top four countries (of 15 Eastern SSA countries) in terms of mortality and DALYs based on the age-standardized
proportion of disease attributable to dietary and metabolic risks.
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Conclusions: In Ethiopia, while there was a decline in mortality and DALYs attributable to CMU over the last two and
half decades, the burden attributable to dietary and metabolic risks have increased during the same period. Lifestyle
and metabolic risks of NCDs require more attention by the primary health care system of the country.
Keywords: Child and maternal undernutrition, Dietary risks, Metabolic risks, Physical activity, Global Burden of Disease,
Ethiopia
Background
Overall prevalence and burden of disease related to un-
dernutrition have declined worldwide [1, 2], with a pre-
diction of further success in reducing the health
problem in regions and nations with the high burden,
such as sub-Saharan African (SSA) countries [3]. At the
same time, the burden of non-communicable diseases
(NCDs) and their behavioral and metabolic risks (MRs)
have increased [1, 2, 4–7]. Particularly, in developing
countries, despite significant progress in tackling under-
nutrition and associated communicable, maternal, neo-
natal and nutritional diseases (CMNNDs), the burden of
NCDs due to a range of health risk factors has increased
[2, 6]. On top of the health sequela associated with child
and maternal undernutrition (CMU) in low-income
countries (LICs), dietary risks (DRs), low physical activ-
ity (LPA) and MRs have contributed to the growing bur-
den of NCDs [4, 8–10]. Evidence also shows CMU in
early life can potentially contribute to the burden of
NCDs [11–16]. The double burden of malnutrition
(over- and undernutrition) with a unique and unusual
(non-classical) pattern of epidemiological transition (per-
sistent high burden of CMNNDs despite the emerging
burden of NCDs) [17–22] is the growing and unprece-
dented challenge for these countries.
Global initiatives have already recognized this pheno-
menon in LICs, and efforts have been geared to tackle
associated factors and challenges [17]. For instance, the
United Nations General Assembly labeled the decade
2015–2025 as the “Decade of Action on Nutrition” with
the aim of improving overall human nutrition [23]. More-
over, 12 of the 17 Sustainable Development Goals (SDGs)
are also related to malnutrition (both under- and overnu-
trition) and other behavioral risk factors. In particular, the
second and third SDGs recognized hunger (undernutri-
tion) and NCDs as major global challenges [24].
Ethiopia has implemented successful national pro-
grams such as primary health care which have led to tre-
mendous public health results, including reduced child
mortality [25] and increased life expectancy [6]. These
achievements were mainly because of the high priority
that the Ethiopian government has placed on its health
policies and programs for CMNNDs, with increased in-
vestments in these areas [26, 27]. On the other hand,
NCDs have been largely ignored in national programs
and strategies despite the existing evidence that shows
the high and increasing burden of NCDs in the country
[20, 28]. Recently, in line with the global initiatives [23,
24], the government of Ethiopia has recognized the im-
portance of addressing communicable diseases, nutri-
tional deficiencies, maternal and neonatal disorders, and
risk factors for NCDs simultaneously [27]. Particularly,
efforts have been focused on reducing the burden of dis-
ease associated with major health risk factors, such as
undernutrition, lifestyle and the MR factors of NCDs
[27, 29]. However, limited and unreliable data on these
risk factors have been a longstanding challenge to meas-
ure the performance of previous programs [26, 30, 31]
and to establish a baseline for future interventions in
Ethiopia [27]. In particular, the relative contribution and
impact of undernutrition, lifestyle and MR factors on the
current disease burden in the country have not been in-
vestigated. The Global Burden of Disease 2015 databases
provide an ideal platform and opportunity to assess the
burden of these factors.
In this study, we aimed to assess the mortality and
disability-adjusted life years (DALYs) attributed to CMU,
DRs, MRs and LPA in Ethiopia using data from the GBD
Study [32]. In addition, we investigated the trend of the
burden attributable to these risk factors between 1990 and
2015 in Ethiopia compared with the other 14 Eastern SSA
countries. Our study will help to understand the current
burden of disease attributable to the risk factors and
evaluate the progress of Ethiopia in addressing these risks
compared to countries in the region. Findings can also
serve as baseline data for planning future interventions
which will further contribute to health and health-related
policies and decision making in the country.
Methods
Study overview
GBD is an international collaborative effort that coordi-
nates resources, including data and expertise, to collate
and disseminate health and health-related evidence at
global, region, sub-region, national and sub-national
levels. It uses comprehensive data sources and rigorous
analysis methods to estimate the burden of disease and
the risk factors [2, 6, 33]. In this study, we use GBD
2015 databases that include estimates of disease burden
and risk factors from 1990 to 2015 [32].
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Details of data sources and collation and computation
process for estimating GBD 2015 risk factors are published
elsewhere [2]. The GBD uses Guidelines for Accurate and
Transparent Health Estimates Reporting (GATHER), a
newly developed tool [34], to report methods and results.
The GBD study also utilizes a comparative risk assessment
(CRA) approach which is based on a causal framework
and hierarchy of risk factors. CRA is an important analyt-
ical approach to gather data on risk factors and to estimate
their relative contribution to a disease burden [35]. Within
the CRA framework, risk factors are organized into four
hierarchies (levels 1 to 4) [35]. In GBD 2015, 79 granular
and specific risks (level 4) were classified into three major
risk aggregates (behavioral, environmental/occupational
and MR), which are at level 1 [2]. Risk-disease pairs with
convincing or probable evidence were included as GBD
2015 risk factors [2, 36].
In our study, estimates of deaths and DALYs attribut-
able to three behavioral risks (CMU, DRs and LPA) and
five MR factors (high systolic blood pressure (SBP), high
fasting plasma glucose (FPG) level, high body mass
index (BMI), high total cholesterol and impaired kidney
function), by sex and age for Ethiopia from 1990 to
2015, are presented. Childhood wasting, underweight
and stunting, non-exclusive breast feeding, discontinued
breast feeding, and iron, vitamin A, and zinc deficiencies
were included under CMU. DR factors (of NCDs) in-
cluded diets low in fruits, vegetables, whole grains, nuts
and seeds, seafood omega-3 fatty acids, calcium, milk,
fiber, polyunsaturated fatty acids, and high in sodium,
processed meat, trans fatty acids, sugar-sweetened bever-
ages and red meat. The risk factors were defined using
the GBD’s definition [2], and their definitions are shown
in Additional file 1: Table S1.
We compared the burden of disease attributable to
CMU, DRs, MRs and LPA with the other 14 Eastern SSA
countries based on the GBD geographical classification
(Burundi, Comoros, Djibouti, Eritrea, Kenya, Madagascar,
Malawi, Mozambique, Rwanda, Somalia, South Sudan,
Tanzania, Uganda, and Zambia). Countries were ranked
from highest (first) to lowest (15th) based on age-
standardized population attributable fraction (PAF) of the
risk factors for all-cause of deaths and DALYs. The PAF
refers to the proportion of disease burden (mortality or
DALYs) attributable to the risk factors [2].
Data sources and exposure levels
Data sources used for each country in the Eastern SSA
countries can be accessed on the Global Health Data Ex-
change (http://ghdx.healthdata.org/). Additional file 1:
Table S2 provides data sources used to estimate exposure
levels of CMU, DRs, MRs and LPA for Ethiopia. For CMU,
data were collated from various sources, including demo-
graphic and health surveys, and the Food and Agriculture
(FAO) Food Balance Sheet, and United Nations Inter-
national Children’s Emergency Fund (UNICEF) and World
Health Organization (WHO) databases [2].
Multiple data sources, including the FAO Food Balance
Sheet and household budget surveys, were used to esti-
mate exposure levels of DRs of NCDs. For trans fatty
acids, availability of partially hydrogenated vegetable
oil packaged foods was used. All DR factors were
standardized to 2000 kcal/day except urinary sodium
and sugar-sweetened beverages. The methods for esti-
mating the burden of disease related to DRs in
Ethiopia have been published previously [37]. For
MRs, data were collated from sources, including sur-
veys, longitudinal studies, published literature which
provided both measured or self-reported MRs. For
LPA, the WHO’s non-communicable disease risk
factor surveys were used [2].
Two main modeling strategies were used to estimate
the exposure levels of risk factors: 1) a spatiotemporal
Gaussian process regression model (ST-GPR) and; 2) a
Bayesian meta-regression model (DisMod-MR 2.1)
which are mixed effect models that borrow information
across geographies (global, super-region, region, nation
and subnational), age, sex, and time. These approaches
allow for the pooling of data from different sources and
adjustment of bias.
Covariates that potentially effect the intake level of indi-
vidual DR factors were incorporated to assist in the pre-
dictions for locations and time where there is a lack of
data. For instance, being landlocked (yes/no) was used to
estimate intake level of seafood omega-3 fatty acids. Ad-
justments, including age-sex splitting, adding study level
covariates, and bias correction for all risk factors were per-
formed [2]. Study level covariates that could potentially
impact the estimates of dietary exposure, such as dietary
data collection methods (i.e., 24-h diet recall, food fre-
quency questionnaire, household budget surveys, or FAO
Food Balance Sheets), were considered in the model.
Country and study level covariates used in the modeling
of DRs are shown in Additional file 1: Table S3.
Relative risks
Relative risks of risk-disease pairs were obtained from
meta-analyses of prospective observational studies or ran-
domized controlled trials. The GBD 2015 risk factors
paper contains detailed methods on how the relative risks
of each of the risk factors were estimated [2]. Metabolic
mediators (through which a risk factor may have an effect)
of DRs are provided in Additional file 1: Table S3.
Attributable mortality and DALYs and uncertainties
The proportion of mortality and DALYs that could have
been prevented if the exposure level of a risk factor had
been sustained at the level associated with the lowest risk
Melaku et al. BMC Public Health  (2018) 18:552 Page 3 of 20
was calculated. The level of exposure that is associated
with the lowest risk is called theoretical minimum-risk ex-
posure level (TMREL). A 20% uncertainty range below
and above the TMREL was applied (Additional file 1:
Table S1).
To determine the mortality and DALYs attributable
to the risk factors, the PAF was firstly determined
using the following inputs: the exposure level for each
risk factor: relative risks, TMREL, and the total num-
ber of deaths from the specific disease. Using the
Monte Carlo approach, the uncertainty of parameters
for exposure, relative risk, attributable mortality and
DALYs [summing up years lived with disability and
years of life lost] were calculated with 1000 repeated
draws. Detailed formulas and computation approaches
are provided elsewhere [2, 6, 33].
In this study, both crude and adjusted estimates of
deaths and DALYs attributed to CMU, DRs, MRs and
LPA are provided. The GBD world population standard
was used for the computation of age-standardized esti-
mates. Results are presented as means with 95% uncer-
tainty intervals (UI) in parenthesis. We calculated
percentage change on the basis of the point estimates.
Results
Burden of disease attributable to CMU, DRs, MRs and LPA
in 2015, Ethiopia (crude estimates)
In 2015, there were 58,783 [43,653–76,020], 66,269
[39,367–106,512], 105,057 [66,167–157,071] and 5808
[3449–9359] estimated deaths attributable to CMU,
DRs, MR and LPA in both sexes in Ethiopia, respect-
ively. Of all deaths, 8.9% [6.1–12.5], 9.7% [7.4–12.3],
15.4% [12.8–17.6] and 0.9% [0.6–1.1] were attributable
to CMU, DRs, MRs and LPA, respectively. These repre-
sent 17.7% [12.8–23.0] deaths due to CMNND, 23.1%
[18.6–28.5], 34.3% [31.3–37.3] and 2.0% [1.4–2.7] due
to NCD deaths, respectively. CMU, DRs, MRs and LPA
were associated with 5,312,975 [4,068,319–6,720,367],
1,698,099 [1,026,366–2,736,469], 2,706,312 [1,755,853–
4,005,055] and 140,484 [84,760–224,637] estimated
DALYs, representing 23.2% [17.5–29.0] of CMNND,
and 11.3% [8.1–15.2], 16.9% [13.5–20.7] and 0.9% [0.6–
1.3] NCD DALYs in 2015 in the country, respectively
(Table 1).
When considering specific risk factors of CMU, child-
hood wasting (13.4% [8.9–18.1]), underweight, (5.2% [3.0–
8.5]), non-exclusive breast feeding (3.3% [1.6–5.5]) and
stunting (3.3% [1.3–6.6]) were the most common contribu-
tors of deaths due to CMNND in 2015. Of the DRs, a diet
low in fruits (8.1% [5.5–10.9]), vegetable (5.2% [2.7–8]),
whole grain (5.0% [3.1–7.2]), nuts and seeds (4.3% [2.7–6.3])
and high in sodium (4.5% [0.8–11.9]) were most com-
mon risks of NCD deaths. Twenty-three percent [20.4–
25.8], 9.7% [8.0–11.5], 6.2% [3.6–9.4], 5.1% [3.4–7.2],
and 4.1% [3.3–5.0] of NCD deaths were attributable to
high SBP, high FPG, high BMI, high total cholesterol
and impaired kidney function, respectively. Childhood
wasting, underweight and stunting, and non-exclusive
breast feeding were the major CMU contributors of
CMNND DALYs. High SBP, high FPG and high BMI
contributed to 9.9% (7.4–12.9), 5.9% (4.9–7.1), and 3.7%
(2.1–5.8) NCD DALYs, respectively (Table 2).
The pattern of mortality and DALYs attributable to DRs,
MRs and LPA by age category are depicted in Figs. 1, 2, 3
and Additional file 1: Figure S1.
Trend of disease burden attributable to CMU, DRs, MRs
and LPA between 1990 and 2015, Ethiopia
Table 3 shows age-standardized death and DALY rates
and proportions, and the percentage change between
1990 and 2015 in Ethiopia. The age-standardized pro-
portion of all deaths attributable to CMU decreased by
more than half over the past 25 years, from 8.6% [6.8–
11.0] in 1990 to 3.6% [2.5–5.1] in 2015. Over the same
period, the age-standardized death rate attributable to
CMU decreased drastically from 231 [185–294] to 44
(33–56) per 100,000 people. The proportion of deaths
attributable to specific types of CMU, particularly
childhood wasting and underweight, also decreased.
However, the proportion of all-cause deaths attributable
to DRs and MRs increased from 10.8% [8.8–13.3] to
14.5% [11.7–18.0] and from 17.0% [15.4–18.7] to 24.2%
[22.2–26.1], respectively. While the proportion of CMNND
related deaths attributable to CMU decreased by half, from
18.4% [14.7–23.6] to 9.9% [7.3–13.4] over the past 25 years,
NCD deaths attributable to DRs (from 10.8% [8.8–13.3] to
14.5% [11.7–18.0]) and MRs (from 17.0% [15.4–18.7] to
24.2% [22.2–26.1]), and LPA (from 1.4% [1.0–1.9] to
1.5% [1.0–1.9]) increased in Ethiopia (Table 3 and
Additional file 1: Figures S2 and S3).
Over the 25 years, the proportion of all-cause and
CMNND DALYs attributable to CMU decreased from
17.3% [13.8–22.3] to 7.4% [5.4–9.9] and from 31.0%
[25.0–38.4] to 17.0% [12.8–22.0], respectively. However,
the proportion of all-cause and NCD DALYs attribut-
able to DRs and MRs increased from 6.1% [5.0–7.4]
to 8.1% [6.1–10.5] and from 9.1% [8.1–10.1] to 13.1
[10.9–15.3], respectively (Table 3 and Additional file 1:
Figures S2 and S3).
Comparison with other East African countries
Comparison of the disease burden attributable to CMU,
DRs, MRs and LPA among each of the 15 East African
countries is shown in Table 4. In all countries, the age-
standardized proportion of mortality attributable to
CMU decreased, with the highest reduction (74.0%) in
Mozambique. In 2015, Ethiopia ranked ninth and 12th in
terms of age-adjusted PAF of deaths and DALYs
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attributable to CMU, respectively. Increases in the bur-
den of disease associated with DRs and MRs were re-
corded for almost all countries. In 2015, Ethiopia was
among the top four Eastern SSA countries with the
highest burden of disease (both in terms of deaths and
DALYs) based on the age-standardized proportion of
disease attributable to DRs, MRs and LPA. Between
1990 and 2015, the country showed a 35.0%, 42.5% and
Table 2 Crude proportion (95% uncertainty interval) of deaths and disability-adjusted life years attributable to specific types of child
and maternal undernutrition, dietary and metabolic risk factors in Ethiopia, 2015
Risk factors Proportion (%) (95% UI)
Deaths Disability-adjusted life years
All causes Communicable, maternal,
neonatal, and nutritional diseases
All causes Communicable, maternal,
neonatal, and nutritional diseases
Child and maternal undernutrition 8.9 (6.1–12.5) 17.7 (12.8–23) 13.0 (9.7–16.8) 23.2 (17.5–29.0)
Childhood undernutrition 7.5 (4.8–11.0) 15.0 (10.3–20.2) 10.8 (7.7–14.4) 19.2 (14–24.7)
Childhood wasting 6.7 (4.2–9.7) 13.4 (8.9–18.1) 9.7 (6.8–12.9) 17.2 (12.2–22.3)
Childhood underweight 2.6 (1.4–4.5) 5.2 (3.0–8.5) 3.8 (2.3–6.1) 6.8 (4.2–10.6)
Childhood stunting 1.7 (0.6–3.5) 3.3 (1.3–6.6) 2.4 (1.0–4.6) 4.2 (1.7–7.9)
Suboptimal breastfeeding 1.7 (0.9–3.0) 3.5 (1.8–5.8) 2.5 (1.3–4.1) 4.4 (2.3–7.2)
Non-exclusive breastfeeding 1.6 (0.8–2.9) 3.3 (1.6–5.5) 2.3 (1.1–3.9) 4.1 (2.0–6.8)
Discontinued breastfeeding 0.1 (0.0–0.3) 0.3 (0.1–0.6) 0.2 (0.1–0.5) 0.3 (0.1–0.8)
Iron deficiency 1.0 (0.7–1.6) 2.1 (1.3–3.2) 1.8 (1.3–2.4) 3.2 (2.3–4.2)
Vitamin A deficiency 0.6 (0.2–2.0) 1.2 (0.4–3.7) 0.9 (0.3–2.6) 1.5 (0.5–4.4)
Zinc deficiency 0.2 (0.0–0.5) 0.3 (0.0–1.0) 0.2 (0.0–0.7) 0.4 (0.0–1.2)
Metabolic risks 0.6 (0.5–0.7) 0.8 (0.5–1.4) 0.2 (0.2–0.2) 0.4 (0.2–0.7)
High fasting plasma glucose 4.5 (3.5–5.4) 0.8 (0.5–1.4) 2.4 (1.8–2.9) 0.4 (0.2–0.7)
All causes Non-communicable diseases All causes Non-communicable diseases
Dietary risks 9.7 (7.4–12.3) 23.1 (18.6–28.5) 4.1 (2.8–5.7) 11.3 (8.1–15.2)
Diet low in fruits 3.4 (2.2–4.7) 8.1 (5.5–10.9) 1.5 (0.9–2.3) 4.2 (2.6–6.1)
Diet low in vegetables 2.2 (1.1–3.4) 5.2 (2.7–8.0) 0.9 (0.4–1.5) 2.5 (1.2–4.1)
Diet low in whole grains 2.1 (1.3–3.1) 5.0 (3.1–7.2) 1.0 (0.6–1.6) 2.8 (1.6–4.4)
Diet high in sodium 1.9 (0.3–4.9) 4.5 (0.8–11.9) 0.8 (0.1–2.0) 2.1 (0.4–5.5)
Diet low in nuts and seeds 1.8 (1.1–2.7) 4.3 (2.7–6.3) 0.8 (0.5–1.3) 2.2 (1.3–3.4)
Diet low in seafood omega-3 fatty acids 1.4 (0.6–2.3) 3.4 (1.4–5.4) 0.5 (0.2–1.0) 1.5 (0.6–2.7)
Diet high in processed meat 0.6 (0.2–1.0) 1.4 (0.5–2.3) 0.3 (0.1–0.5) 0.8 (0.4–1.4)
Diet high in trans fatty acids 0.4 (0.1–0.7) 0.9 (0.3–1.7) 0.2 (0.1–0.4) 0.5 (0.2–1.0)
Diet suboptimal in calcium 0.1 (0.1–0.2) 0.3 (0.2–0.5) 0.1 (0.0–0.1) 0.2 (0.1–0.2)
Diet high in sugar-sweetened beverages 0.0 (0.0–0.1) 0.1 (0.1–0.1) 0.0 (0.0–0.0) 0.1 (0.0–0.1)
Diet low in milk 0.1 (0.0–0.2) 0.2 (0.1–0.4) 0.0 (0.0–0.1) 0.1 (0.0–0.2)
Diet high in red meat 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.0) 0.0 (0.0–0.1)
Diet low in fiber 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.0) 0.0 (0.0–0.1)
Diet low in polyunsaturated fatty acids 0.0 (0.0–0.1) 0.1 (0.0–0.1) 0.0 (0.0–0.0) 0.0 (0.0–0.1)
Metabolic risks 15.4 (12.8–17.6) 34.3 (31.3–37.3) 6.5 (4.9–8.3) 16.9 (13.5–20.7)
High systolic blood pressure 9.6 (7.9–11.3) 23.1 (20.4–25.8) 3.6 (2.5–4.8) 9.9 (7.4–12.9)
High fasting plasma glucose 9.7 (8.0–11.5) 5.9 (4.9–7.1)
High body-mass index 2.6 (1.4–4.0) 6.2 (3.6–9.4) 1.4 (0.7–2.1) 3.7 (2.1–5.8)
High total cholesterol 2.1 (1.4–3.1) 5.1 (3.4–7.2) 0.9 (0.5–1.3) 2.4 (1.5–3.6)
Impaired kidney function 1.7 (1.3–2.1) 4.1 (3.3–5.0) 0.8 (0.6–1.0) 2.3 (1.8–2.8)
UI uncertainty interval; Zero (0.0) indicates very low proportion. The sum of percentages of risk factors in a column exceeds the total for all risk factors combined
under a risk factor cluster because of an overlap between various risk factors
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54.1% increase in age-standardized proportion of deaths
attributable to DRs, MRs and LPA, respectively. In 2015,
the age-specific pattern of disease burden (PAF and rates
of death and DALYs) attributable to MRs and LPA in
Ethiopia was similar with the average age-specific esti-
mates pattern of Eastern SSA countries. The pattern of
age-specific disease burden attributable to DRs was rela-
tively higher for Ethiopia compared to the average of
Eastern SSA countries, although it was not significantly
different based on the uncertainty intervals (data not
shown).
Discussion
This systematic investigation of disease burden attribut-
able to CMU, DRs, MRs and LPA in Ethiopia and the
comparison with other 14 Eastern SSA countries pro-
vides, for the first time, a comprehensive picture of mor-
tality and DALYs attributable to nutritional, lifestyle and
metabolic factors. Despite a significant reduction in
CMU-attributable disease, there was an increasing trend
for the burden of disease attributable to DRs, LPA, and
MRs in the country. Our findings show that while a high
burden of CMU-attributable disease still remains, the
burden attributable to DRs, LPA and MRs is also high
and continues to increase. We found that 9%, 10%, and
15% of all-cause mortality in Ethiopia were attributable
to CMU, DRs, and MRs, respectively. Ethiopia was
among four Eastern SSA countries with the highest bur-
den of disease (both in terms of deaths and DALYs)
based on the age-standardized proportion of disease at-
tributable to DRs, MRs and LPA in 2015. These results
call for an increased investment in prevention and con-
trol of the aforementioned risk factors.
Of the 17 risk factors (level 2) in GBD 2015 [38], DRs,
high SBP and CMU were the second (behind air pollu-
tion), third and fourth most common risk factors of deaths
in Ethiopia, respectively. In terms of DALYs, CMU was
still a leading risk factor in the country. DRs and high SBP
were the fifth (behind CMU, air pollution, unsafe water,
sanitation, and handwashing, and unsafe sex) and sixth
most common risk factors, respectively. High FPG (sev-
enth), overweight/obesity (ninth), high total cholesterol
(11th) and low GFR (12th) were also common risk factors
of deaths in the country. However, of the seven clusters
Fig. 1 Rate and proportion (95% uncertainty interval) of deaths and disability-adjusted life years (DALYs) attributable to dietary risk factors by age in
Ethiopia, 2015 (Proportion was calculated out of all-cause of death)
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(level 2) of behavioral risk factors, DRs were the leading
contributors for deaths in the country and the third
(behind CMU and unsafe sex) for DALYs [38].
In our study, we found that, based on age-standardized
proportion of death in 2015, DRs and MRs were respon-
sible for more deaths than the CMU in Ethiopia. Diets low
in fruits, vegetables, nuts and seeds, and whole grains and
high in sodium were the most common five DRs, each ac-
counting for 2% or more of all-cause deaths, and more
than 4% of all-cause DALYs in the country. It is worth
noting that the issue of diet-related NCD burden is not
only a concern among high-income countries [2, 39]. In
our previous study, we have discussed the need for coordi-
nated efforts to reduce the high burden of disease related
to DR factors of NCDs in Ethiopia [37]. Similarly, a recent
(2016) report [40] indicated that the consumption of fruit
and vegetables was very minimal—only 2.4% of the popu-
lation aged 15–65 years old consumed five or more serv-
ings of fruit and vegetables per day in Ethiopia. In 2011, it
is reported that cereals (“Teff”, wheat, barley, maize, sor-
ghum and other cereals) contributed to the majority (43%)
of food consumed (kg/adult equivalent/year) in Ethiopia,
while the consumption of vegetables and fruits (10.5%),
pulses (5.1%), animal products (4.6%) and oilseeds (0.1%)
was low [41]. This suggests that the food pattern in the
country is “monotonous” and minimally diversified, which
increases the risk of susceptibility for NCDs [42], micro-
nutrient deficiencies and their associated adverse health
outcomes [43].
In addition, the prevalence of alcohol consumption
(consumption of alcohol in the past 30 days), tobacco
smoking [current tobacco users (daily and non-daily)],
and LPA (less than 600 metabolic equivalent time-
minutes) in Ethiopia was 41%, 4%, and 6%, respectively
[40]. MRs are also major contributors to the high
burden of NCDs in the country. A considerable
prevalence of overweight/obesity (16%), high triglycer-
ide [> 150 mg/dl] (21%), raised blood pressure (22%)
and high FPG or diabetes (6%) has been reported [40],
which suggests the public health importance of these
risk factors. The GBD study also found that the preva-
lence of overweight/obesity among people 20 years and
above has significantly increased from 6% (5–7) in 1990
to 14% (12–17) in 2015 in Ethiopia [44]. This highlights
Fig. 2 Rate and proportion (95% uncertainty interval) of deaths and disability-adjusted life years (DALYs) attributable to metabolic risk factors by age in
Ethiopia, 2015 (Proportion was calculated out of all-cause of death)
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the need for coordinated effort and investment to im-
prove dietary quality, create a favorable environment
for physical activity and implement strategies for early
screening and control of MRs in the country parallel to
the continuing investments on CMU.
Although the burden of CMU-attributable disease has
decreased over the past 25 years, the burden is still signifi-
cantly high in Ethiopia. At the same time, there is also a
high burden of NCDs attributable to suboptimal diet and
MR factors in the country. Whereas the age-adjusted pro-
portion of mortality due to NCDs in Ethiopia significantly
increased by 35%, from 42% (39–45) in 1990 to 57% (54–
60) in 2015, deaths due to CMNNDs decreased by 23%,
from 47% (44–50) to 36% (33–39) over the same time
frame [38]. In addition to the increased burden of DR, life-
style and MR factors, multiple determinants could have
contributed to the dynamics of disease burden in the
country. Health and health-related interventions (including
policies and related investments) in curbing and control-
ling CMNNDs and the risk factors in the country might
have contributed to the current pattern of disease burden
[27, 45]. The increased life expectancy [6] in the country
could be a proxy evidence for the changes in disease dy-
namics and the impact of the interventions. Between 1990
and 2015, the estimated life-expectancy at birth increased
from 43 to 64 years [46], and it was the top-ranked
increase.
Furthermore, previous exposure to food deprivation
and undernutrition (particularly during childhood) could
exacerbate the current burden of lifestyle and metabolic
diseases. It is well recognized that childhood undernutri-
tion increases the susceptibility of adults to NCDs (“fetal
origin” hypothesis) [47–49]. Several mechanisms were
proposed for this association, including structural
changes of organs [50], preference for fatty foods and in-
creased risk of dyslipidemia [51], and epigenetic change
[13, 14]. Epidemiological studies have demonstrated that
early famine exposure increased the risk for a range of
NCDs [52–55], metabolic diseases [52, 54, 56, 57] and
overweight/obesity [57]. Evidence also shows that an
Fig. 3 Rate and proportion (95% uncertainty interval) of deaths and disability-adjusted life years (DALYs) attributable to low physical activity by age in
Ethiopia, 2015 (Proportion was calculated out of all-cause of death)
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early-life exposure to food deprivation could modify the
risk of complications of NCDs [58]. Evidence of the im-
pact of previous famine history on the current burden of
disease in Ethiopia is lacking, warranting further investi-
gations in the area.
Ethiopia has successfully implemented large-scale
measures that have improved public health, particularly
in reducing CMNNDs [2]. For instance, the country
achieved MDG-5 (reducing under-five mortality by two-
thirds) in 2013 [25]. Successful public health strategies
on the risk factors of child mortality [2, 25, 31] through
expansion of primary health care has brought a signifi-
cant reduction in child mortality. Our study also
highlighted that CMU-attributed mortality and DALYs
have significantly declined over the past 25 years, al-
though the burden is still significantly high. At the same
time, diet-, lifestyle- and overweight/obesity-related dis-
eases are high and increasing, creating a further chal-
lenge in the health care system and services of the
country. Compared to other Eastern SSA countries,
Ethiopia was among the top four countries with high
burden of disease attributable to DRs, MRs and LPA,
while Kenya had the lowest burden of disease related to
these risk factors. In addition to its national health pol-
icy, the Kenyan government and its partners have devel-
oped a national strategy for prevention and control of
NCDs (2015–2020) [59] with the purpose of providing
more specific emphasis on interventions against NCDs
and their risk factors. This strategic plan provides a plat-
form to specifically focus on reducing NCD risk factors,
allocating resources and designing tailored and coordi-
nated interventions against NCDs.
In Ethiopia, although there have been efforts to prevent
and control NCDs [27, 60], interventions against the high
and growing burden of disease attributable to DRs, lifestyle,
and MRs is minimal. Therefore, while continuing to invest
in CMU-attributed disease and the risk factors, it is impera-
tive to design appropriate response for the growing burden
of disease related to suboptimal diet, lifestyle and MR fac-
tors in line with the global initiatives [17, 23, 24]. In
addition to the Health Sector Transformation Plan [27], de-
signing a comprehensive and evidence based plan that spe-
cifically targets reducing NCD burden and risk factors by
sharing experience from other countries with a similar en-
vironment (such as Kenya) is necessary. Revision of the
NCD strategic framework [30] based on latest evidence
should be undertaken. Dietary guidelines and policy should
be developed to promote and guide healthy eating behav-
iors and regulate food supply in the country. Further, des-
pite the high burden of disease attributable to suboptimal
diet and MR, data on food and nutrient intake, behavioral
factors and metabolic markers of NCDs in Ethiopia are very
limited. As part of the investments, the gap in nationally
representative individual level data on these key risk factors
should be addressed by establishing a national level surveil-
lance system and expanding (in terms of both coverage and
depth) health and demographic surveillance sites in the
country. Studies should also further investigate the impact
of previous food deprivation and undernutrition on the
current burden of NCDs in the country.
This study is not without limitations in spite of the
fact that we have used data from GBD that uses robust
methods to collate and analyze data. Detailed methodo-
logical shortfalls of the overall estimation process and
risk factors have been discussed elsewhere [2, 37]. Spe-
cific limitations to the current study are discussed here.
First, shortage of data, particularly on DRs, MRs and
LPA, is a major challenge to estimating the exposure
level. To assist in addressing this, the modeling strat-
egies ST-GPR and DisMod-MR 2.1 were used, where
data from the region, super-region and global levels con-
tributed to country level estimates. However, the uncer-
tainty intervals of the estimates are wider for these risk
factors. Secondly, we did not assess the difference be-
tween urban versus rural area estimates, and differences
across regions, as the distribution of risk factors and dis-
ease burden could potentially be different in these set-
tings [40]. Thirdly, the correlation among risk factors
(for instance, among DR factors) is another potential
limitation. Fourthly, residual confounding could affect
the estimates of relative risks. Lastly, the use of similar
effect size (relative risks) across countries (for a given
age-sex category) could be a potential drawback as the
effect of a risk factor in different population groups
could have a different effect on a disease outcome [2].
Conclusions
In summary, while Ethiopia has significantly reduced the
burden of CMU attributable disease, the burden attribut-
able to DRs and MRs of NCDs, and LPA increased over
the past 25 years. However, despite the reduction, the bur-
den of disease attributable to CMU is still a public health
problem. In 2015, a higher age-standardized proportion of
deaths were due to diseases attributable to DRs and MRs
of NCDs compared to those CMU-attributed. This reflects
the country’s success and challenge in curbing nutrition-,
metabolic- and lifestyle-related diseases. To effectively
mitigate the challenge, policies should target DRs, MRs
and other behavior-related factors in addition to the ef-
forts to reduce undernutrition. Given the enormous cost
of diseases associated with lifestyle factors and MRs for
the individual and the healthcare system, future invest-
ments on the scaling-up of prevention and control of
these risk factors are required to effectively address the
growing health challenge in Ethiopia. Policies and guide-
lines should be designed to mitigate the behavioral and
MR factors during the SDG era. A collective and inte-
grated multi-sectoral approach is required to successfully
Melaku et al. BMC Public Health  (2018) 18:552 Page 17 of 20
prevent and control NCDs and their risk factors. Lifestyle
and MRs of NCDs also require more attention in the pri-
mary health care system. In this regard, replicating the
primary health care approach, which has been successful
in reducing CMNND, could bring further success in pre-
vention and control of NCDs and their risk factors. The
establishment of a community-based national surveillance
system to collate determinants of NCDs in the country,
such as dietary, behavioral and metabolic factors, will
further assist the anticipated interventions.
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